TIDMSHP
RNS Number : 5058M
Societe Generale SA
08 January 2019
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if
different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust,
the trustee(s),
settlor and beneficiaries must be named.
-------------------------------------------
(c) Name of offeror/offeree in relation to whose relevant securities Shire Plc
this form relates:
Use a separate form for each offeror/offeree
-------------------------------------------
(d) If an exempt fund manager connected with an offeror/offeree, state
this and specify identity
of offeror/offeree:
-------------------------------------------
(e) Date position held/dealing undertaken: 07/01/2019
For an opening position disclosure, state the latest practicable date
prior to the disclosure
-------------------------------------------
(f) In addition to the company in 1(c) above, is the discloser YES: Takeda Pharmaceutical Company Limited
making disclosures in respect
of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
-------------------------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: Ordinary shares: 19,812,373 Shares Interests and 58,714 short position
ADR (referencing the ordinary): 322,266 equivalent Shares interests and 41,643
equivalent
Shares as short position
Where (1 ADR = 3 ordinary shares)
Interests Short positions
------------------------------------------- -------------------------------------------
Number % Number %
--------------------------- --------------------------- --------------
(1) Relevant securities
owned and/or controlled: 20,134,639 2.19 100,357 0.01
--------------------------- -------------- --------------------------- --------------
(2) Cash-settled
derivatives: 0 0.00 19,399,108 2.11
--------------------------- -------------- --------------------------- --------------
(3) Stock-settled
derivatives (including
options) and agreements to
purchase/sell: 593,100 0.06 473,700 0.05
--------------------------- -------------- --------------------------- --------------
TOTAL: 20,727,739 2.26 19,973,165 2.18
--------------------------- -------------- --------------------------- --------------
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of Purchase/sale Number of securities Price per
relevant unit
security GBP
Ordinary Purchase - -
---------------- --------------------- ----------
Class of Purchase/sale Number of securities Price per
relevant unit
security USD
---------------- --------------------- ----------
ADR Purchase - -
---------------- --------------------- ----------
Class of Purchase/sale Number of securities Price per
relevant unit
security GBP
---------------- --------------------- ----------
Ordinary Sale - -
---------------- --------------------- ----------
Class of Purchase/sale Number of securities Price per
relevant unit
security USD
---------------- --------------------- ----------
ADR Sale - -
---------------- --------------------- ----------
Total Purchases -
---------------- --------------------- ----------
Total Sales -
---------------- --------------------- ----------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit GBP
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
closing a short
Ordinary Listed call warrant position 40 18.95
--------------------- ----------------------- ----------------------- -------------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit USD
relates etc.
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit GBP
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable) GBP
e.g. subscription, conversion
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the person making the disclosure and any party to the offer or
any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person
making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? Yes
Date of disclosure: 08/01/2019
Contact name: Olivier Vero
-----------------
Telephone number: +44 20 7676 6969
-----------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.The Code can be viewed on the Panel's website
at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION)
POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure: SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Shire Plc
--------------------
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
-
Class of Product Written Number Exercise price Type Expiry date
relevant description or purchased of securities per unit USD
security e.g. call to which
option option
or derivative
relates
e.g. American,
European etc.
---------------- ---------------
Listed American
ADR call-option Purchase 75,000 170 option 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Sale 75,000 165 option 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Purchase 41,800 175 option 18/04/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Purchase 360,600 180 option 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Sale 226,900 175 option 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Purchase 41,800 200 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Sale 15,000 185 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Purchase 33,900 190 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR call-option Sale 20,000 172.5 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR put-option Sale 20,000 170 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR put-option Purchase 116,800 165 option 18/04/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR put-option Purchase 20,000 140 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
Listed American
ADR put-option Sale 20,000 155 options 18/01/2019
---------------- --------------- --------------- ---------------- --------------- ------------
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the
interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form
(Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be
stated.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RETEANFPESENEEF
(END) Dow Jones Newswires
January 08, 2019 04:51 ET (09:51 GMT)
Shire (LSE:SHP)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Shire (LSE:SHP)
Gráfica de Acción Histórica
De May 2023 a May 2024
